September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
August 19th 2024
The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Study: At-home COVID-19 Tests Less Effective After Omicron Emergence
The performance of 3 commercially available COVID-19 home-testing kits worsened during the emergence of the omicron variant, according to a new cross-sectional study.
COVID-19 Bivalent Booster Shot Q&A for Clinicians
Get answers to 7 questions you may have regarding bivalent booster dose vaccination for patients from the US Centers for Disease Control and Prevention.
The Future of US Antimicrobial Resistance is in Our Hands and There is Work to Do
Steer clear of antibiotic Rxs whenever possible, says Anne Meneghetti, MD, to help the US get back to pre-COVID levels of antimicrobial stewardship.
Primary Care Can Help Restore US Antibiotic Stewardship, Starting with Flu Shots
Preventing viral infections with vaccination can keep the most vulnerable out of the hospital, reducing the risk of bacterial superinfections.
Superinfection Rate in Hospitalized COVID-19 Patients was Found to be Low
Only 9% of inpatients with COVID-19 had a bacterial superinfection that could be treated with antibiotics which curbed use of broad-spectrum antimicrobials.
Pfizer Reports Positive Topline Phase 3 Data for Bivalent RSV Vaccine in Older Adults
Pfizer announced that a single dose of the vaccine, RSVpreF, demonstrated 85.7% efficacy against severe disease, defined by ≥3 symptoms.
Antimicrobial Resistance During COVID-19 Gained New Ground: Expert Perspective
Widespread antibiotic prescribing in the first year of the pandemic set back US progress on the fight against antimicrobial resistance, says Anne Meneghetti, MD.
New Real-world Study Finds Average Length of COVID-19 Infectiousness is 5 Days
A new real-world study found that two-thirds of patients with COVID-19 were still infectious 5 days and one-fourth at 7 days after symptom onset.
FDA: Repeat At-home COVID-19 Antigen Tests to Reduce Risk of False Negative Result
The FDA now recommends serial testing following a negative result on any at-home COVID-19 antigen test to reduce the risk of a false negative result.
New CDC COVID-19 Guidelines Reduce Quarantine Requirement after Exposure
After exposure to COVID-19, asymptomatic individuals in low-risk settings no longer need to quarantine, says the CDC; masking is still recommended.
5 Clinical Updates in Tick-borne Disease Research
Lyme disease vaccine being tested in phase 3 trial, Lyme disease diagnoses up 357%, and 3 more updates on tick-borne diseases.
FDA EUA for Monkeypox Virus Vaccine Expands Available Doses by 5-Fold
A smaller dose given by intradermal injection will expand the total US supply by a factor of 5, FDA says.
Monkeypox Declared US Public Health Emergency by HHS
Monkeypox will now be treated as a public health emergency in the US where the outbreak has become the largest in the world, according to authorities.
Impact of HPV Vaccination in US is Rising, and Herd Immunity is Getting Stronger, According to New Research
Investigators from CDC warned, however, that HPV vaccinations missed due to the COVID-19 pandemic could stymie this progress.
Polio Case in the US in Same NY Community that Harbored Measles Outbreak in 2018-19
The first US polio case in more than a decade was found in vaccination-poor Rockland County, NY, where the virus has now been found in wastewater.
A Fever of Unknown Origin: When a Thorough History is an Afterthought
When a workup begins with lab tests a thorough history can be an afterthought. Before this patient had a blind liver biopsy, case author Dr Rodger MacArthur asked some simple questions.
Monkeypox Quick Take: What do Americans Think, Believe, Fear?
A new survey of monkeypox outbreak perceptions among US adults offers primary care clinicians a quick take on what their patients may be thinking.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 27, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 26, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Monkeypox Virus Questions & Answers for Family Physicians: Highlights from an AAFP Conversation
A public health expert sat down with the American Academy of Family Physicians to answer some common questions about the virus. Get the topline, here.
Monkeypox: WHO Declares Public Health Emergency of International Concern
The WHO's highest level of alert indicates the organization's belief that the now multicountry monkeypox outbreak requires a coordinated international response.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 22, 2022
Risks for Diabetes and CVD Spike in Early COVID-19 Infection, May Diminish Over 12 Months
Type 1 diabetes diagnoses increased by 81% during the 4-week acute phase of COVID-19 in UK patients and CVD diagnoses rose 6-fold, according to a large population-based study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 20, 2022
Monkeypox Treatments May be Close at Hand
There are no specific drugs to treat the monkeypox virus but research into existing antivirals is well under way to determine their potential efficacy.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 19, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 18, 2022
Refugee Immunization Requirements: A Pop Quiz
Refresh your memory on refugee immunization recommendations with a 3-question quiz based on a patient scenario.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 12, 2022